Results 31 to 40 of about 900,371 (377)

RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers [PDF]

, 2012
BACKGROUND Atrial fibrillation is a serious public health problem posing a considerable burden to not only patients, but the healthcare environment due to high rates of morbidity, mortality, and medical resource utilization. There are limited data on the
AJ Camm, Aldo P Maggioni, Alexandra A Bernhardt, Alfonso Martín, Anselm K Gitt, AS Go, B Lown, BN Singh, CA Sanoski, CX Wong, François Chazelle, Gregory YH Lip, GV Naccarelli, H Stefansdottir, Harry JGM Crijns, Hemant M Phatak, IC Van Gelder, IC Van Gelder, J Heeringa, Jean-Yves Le Heuzey, JML Hendriks, K Wachtell, Lori D Bash, Mauricio Scanavacca, MM Gallagher, Mårten Rosenqvist, P Alboni, Piotr Ponikowski, Prashanthan Sanders, R Pisters, RG Tieleman, S DeWilde, Sreevalsa Unniachan, T Meinertz, Thorsten Lewalter, VE Hagens, Y Miyasaka   +36 more
core   +3 more sources

Anxiety and Depression Prevalence and Risk Factors Among Patients With Cardiovascular Diseases in Post-COVID-19 China

Frontiers in Public Health, 2022
Objective: Data are limited on the psychological disorders of patients with cardiovascular disease during the post-COVID-19 period, although mental health status is associated with morbidity and mortality.
Minglan Wu, Minglan Wu, Liying Shen, Qiqi Wang, Li Liu, Sen Lu, Jianmei Jin, Zhen Dai, Zheyue Shu   +8 more
doaj   +1 more source

Edoxaban versus warfarin in patients with atrial fibrillation.

New England Journal of Medicine, 2013
BACKGROUND Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known.
R. Giugliano, C. Ruff, E. Braunwald, S. Murphy, S. Wiviott, J. Halperin, A. Waldo, M. Ezekowitz, J. Weitz, J. Špinar, W. Rużyłło, M. Ruda, Y. Koretsune, Joshua Betcher, M. Shi, L. Grip, Shirali P Patel, Indravadan Patel, J. Hanyok, M. Mercuri, E. Antman   +20 more
semanticscholar   +1 more source

My atrial fibrillation is not your atrial fibrillation [PDF]

European Heart Journal, 2017
Abstract not available ; Paulus Kirchhof and Prashanthan ...
Paulus Kirchhof, Paulus Kirchhof, Prashanthan Sanders   +2 more
openaire   +4 more sources

Atrial Fibrillation [PDF]

Heart Lung <html_ent glyph="@amp;" ascii="&amp;"/> Circulation, 2003
Atrial fibrillation (AF) is a hetrogeneous disease that may present in many forms. Advances in our understanding of the mechanism responsible for AF have led to exciting new therapies that may soon provide a definitive cure.
openaire   +4 more sources

Prognostic Potential of Heart Rate and Hypertension in Multiple Myeloma Patients

Frontiers in Cardiovascular Medicine, 2021
Background: The prognosis of patients with multiple myeloma (MM) is variable and partly depends on their cardiovascular status. The presence of arrhythmias can lead to worse outcomes.
Jie Wang, Jie Wang, Manyun Tang, Yunxiang Long, Jingzhuo Song, Limei Chen, Mengchang Wang, Yongxin Li, Chaofeng Sun, Yang Yan   +9 more
doaj   +1 more source

Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure

Circulation, 2021
Supplemental Digital Content is available in the text. Background: In patients with heart failure and atrial fibrillation (AF), several clinical trials have reported improved outcomes, including freedom from AF recurrence, quality of life, and survival ...
D. Packer, J. Piccini, K. Monahan, H. Al-Khalidi, A. Silverstein, P. Noseworthy, J. Poole, T. Bahnson, Kerry L Lee, D. Mark   +9 more
semanticscholar   +1 more source

The Value of Voltage Histogram Analysis Derived Right Atrial Scar Burden in the Prediction of Left Atrial Scar Burden

Cardiology Research and Practice, 2020
Introduction. Growing evidence suggests that fibrotic changes can be observed in atrial fibrillation (AF) in both atria. Quantification of the scar burden during electroanatomical mapping might have important therapeutic and prognostic consequences ...
Szilvia Herczeg, Joseph Galvin, John J. Keaney, Edward Keelan, Roger Byrne, Claire Howard, Laszlo Geller, Gabor Szeplaki   +7 more
doaj   +1 more source

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

New England Journal of Medicine, 2011
BACKGROUND The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment.
M. Patel, K. Mahaffey, Jyotsna Garg, Guohua Pan, D. Singer, W. Hacke, G. Breithardt, J. Halperin, G. Hankey, J. Piccini, R. Becker, C. Nessel, J. Paolini, S. Berkowitz, K. Fox, R. Califf   +15 more
semanticscholar   +2 more sources

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.

New England Journal of Medicine, 2022
BACKGROUND Atrial fibrillation is a chronic, progressive disorder, and persistent forms of atrial fibrillation are associated with increased risks of thromboembolism and heart failure.
J. Andrade, M. Deyell, L. Macle, G. Wells, M. Bennett, V. Essebag, J. Champagne, J. Roux, D. Yung, A. Skanes, Y. Khaykin, Carlos Morillo, U. Jolly, P. Novak, Evan Lockwood, G. Amit, P. Angaran, John Sapp, Stephan Wardell, S. Lauck, Julia Cadrin-Tourigny, S. Kochhäuser, A. Verma   +22 more
semanticscholar   +1 more source